Naundorf H - Search Results

1

Differences in immunoreactivity of estrogen receptor (ER) in tamoxifen-sensitive and -resistant breast carcinomas: preclinical and first clinical investigations.

Naundorf H, Jost-Reuhl B, Becker M, Reuhl T, Neumann C, Fichtner I. Naundorf H, et al. Breast Cancer Res Treat. 2000 Mar;60(1):81-92. doi: 10.1023/a:1006334131241. Breast Cancer Res Treat. 2000. PMID: 10845812

2

Establishment and characteristics of two new human mammary carcinoma lines in nude mice with special reference to the estradiol receptor status and the importance of stroma for in vivo and in vitro growth.

Naundorf H, Fichtner I, Elbe B, Saul GJ, Haensch W, Zschiesche W, Reinecke S. Naundorf H, et al. Breast Cancer Res Treat. 1994;32(2):187-96. doi: 10.1007/BF00665769. Breast Cancer Res Treat. 1994. PMID: 7865848

3

Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.

Fichtner I, Zeisig R, Naundorf H, Jungmann S, Arndt D, Asongwe G, Double JA, Bibby MC. Fichtner I, et al. Among authors: naundorf h. Breast Cancer Res Treat. 1994;32(3):269-79. doi: 10.1007/BF00666004. Breast Cancer Res Treat. 1994. PMID: 7865855

4

Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and -negative breast carcinomas.

Naundorf H, Parczyk K, Zschiesche W, Reinecke S, Büttner B, Saul GJ, Sinn B, Fichtner I. Naundorf H, et al. J Cancer Res Clin Oncol. 1996;122(1):14-20. doi: 10.1007/BF01203068. J Cancer Res Clin Oncol. 1996. PMID: 8543587

5

Development and characterization of a tamoxifen-resistant breast carcinoma xenograft.

Naundorf H, Becker M, Lykkesfeldt AE, Elbe B, Neumann C, Büttner B, Fichtner I. Naundorf H, et al. Br J Cancer. 2000 Jun;82(11):1844-50. doi: 10.1054/bjoc.2000.1156. Br J Cancer. 2000. PMID: 10839300 Free PMC article.

6

Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives.

Naundorf H, Rewasowa EC, Fichtner I, Büttner B, Becker M, Görlich M. Naundorf H, et al. Breast Cancer Res Treat. 1992;23(1-2):87-95. doi: 10.1007/BF01831480. Breast Cancer Res Treat. 1992. PMID: 1446057

7

Carboplatin-liposomes (CPL) in immunodeficient mice: improved antitumor activity for breast carcinomas and stimulation of hematopoiesis.

Fichtner I, Reszka R, Goan SR, Naundorf H. Fichtner I, et al. Among authors: naundorf h. Med Oncol. 1994;11(3-4):111-9. doi: 10.1007/BF02999858. Med Oncol. 1994. PMID: 7633830

8

Establishment and characteristics of two new human mammary carcinoma lines serially transplantable in nude mice.

Naundorf H, Fichtner I, Saul GJ, Haensch W, Büttner B. Naundorf H, et al. J Cancer Res Clin Oncol. 1993;119(11):652-6. doi: 10.1007/BF01215983. J Cancer Res Clin Oncol. 1993. PMID: 8102371

9

Influence of liposomes rich in unsaturated or saturated fatty acids on the growth of human xenotransplanted mammary carcinomas and on the levels of heart type fatty acid binding protein.

Naundorf H, Zschiesche W, Reszka R, Fichtner I. Naundorf H, et al. In Vivo. 1995 May-Jun;9(3):247-51. In Vivo. 1995. PMID: 8562891

10

Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.

Stein U, Walther W, Lemm M, Naundorf H, Fichtner I. Stein U, et al. Among authors: naundorf h. Int J Cancer. 1997 Sep 4;72(5):885-91. doi: 10.1002/(sici)1097-0215(19970904)72:5<885::aid-ijc28>3.0.co;2-6. Int J Cancer. 1997. PMID: 9311609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters